LAVA Therapeutics NV: Nasdaq/NYSE listing notice — LAVA Therapeutics receives Nasdaq deficiency notice; shares below $1.00 for 30 days

LAVA Therapeutics NV

Nasdaq notified LAVA on Feb 27, 2025, that its common shares failed to meet the $1.00 minimum bid price for 30 consecutive business days.
Company has 180 days, until Aug 26, 2025, to regain compliance by closing at $1.00+ for 10 consecutive trading days.
Failure could lead to transfer to Nasdaq Capital Market for an additional 180-day cure period if eligibility criteria are met.
LAVA will monitor bid price and consider available options; no assurance of regaining compliance.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

LAVA Therapeutics NV received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5450(a)(1)

Exact text from the filing

February 27, 2025, LAVA Therapeutics N.V. (the “Company”) received a notice from The Nasdaq Stock Market (“Nasdaq”) that the Company is not in compliance with Nasdaq’s Listing Rule 5450(a)(1), as the minimum bid price of the Company’s common shares has been below $1.00 per share for 30 consecutive business days. The notification of noncompliance has no immediate effect on the listing or trading of the Company’s common shares on The Nasdaq Global Select Market. The Company has 180 calendar days, or until August 26, 2025, to regain compliance with the minimum bid price requirement. To regain com

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001104659-25-019127

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.